Table of Contents Author Guidelines Submit a Manuscript
International Journal of Vascular Medicine
Volume 2010, Article ID 490241, 6 pages
http://dx.doi.org/10.1155/2010/490241
Research Article

A Quantitative Trait Locus on Chromosome 5p Influences D-Dimer Levels in the San Antonio Family Heart Study

1Department of Genetics, Southwest Foundation for Biomedical Research, San Antonio, TX 78245-0549, USA
2Department of Pathology, University of Vermont, Colchester, VT 05446, USA
3Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA

Received 28 January 2010; Accepted 4 June 2010

Academic Editor: Marc A. Passman

Copyright © 2010 V. P. Diego et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. J. Sidelmann, J. Gram, J. Jespersen, and C. Kluft, “Fibrin clot formation and lysis: basic mechanisms,” Seminars in Thrombosis and Hemostasis, vol. 26, no. 6, pp. 605–618, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Danesh, P. Whincup, M. Walker et al., “Fibrin D-dimer and coronary heart disease prospective study and meta-analysis,” Circulation, vol. 103, no. 19, pp. 2323–2327, 2001. View at Google Scholar · View at Scopus
  3. A. R. Folsom, N. Aleksic, E. Park, V. Salomaa, H. Juneja, and K. K. Wu, “Prospective study of fibrinolytic factors and incident coronary heart disease: the atherosclerosis risk in communities (ARIC) study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 4, pp. 611–617, 2001. View at Google Scholar · View at Scopus
  4. G. D. O. Lowe, J. W. G. Yarnell, A. Rumley, D. Bainton, and P. M. Sweetnam, “C-reactive protein, fibrin d-dimer, and incident ischemic heart disease in the speedwell study: are inflammation and fibrin turnover linked in pathogenesis?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 4, pp. 603–610, 2001. View at Google Scholar · View at Scopus
  5. G. D. O. Lowe, A. Rumley, A. D. McMahon, I. Ford, D. St. J. O'Reilly, and C. J. Packard, “Interleukin-6, fibrin D-dimer, and coagulation factors VII and XIIa in prediction of coronary heart disease,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 8, pp. 1529–1534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. A. D. Pradhan, A. Z. LaCroix, R. D. Langer et al., “Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women,” Circulation, vol. 110, no. 3, pp. 292–300, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. D. Langer, A. D. Pradhan, C. E. Lewis et al., “Baseline associations between postmenopausal hormone therapy and inflammatory, haemostatic, and lipid biomarkers of coronary heart disease. The women's health initiative observational study,” Thrombosis and Haemostasis, vol. 93, no. 6, pp. 1108–1116, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Yarnell, E. McCrum, A. Rumley et al., “Association of European population of levels of thrombotic and inflammatoy factors with risk of coronary heart disease: the MONICA Optional Haemostasis Study,” European Heart Journal, vol. 26, no. 4, pp. 332–342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Berge, P. Friis, and P. M. Sandset, “Hemostatic activation in acute ischemic stroke,” Thrombosis Research, vol. 101, no. 2, pp. 13–21, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Di Napoli and F. Papa, “Inflammation, hemostatic markers, and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients,” Stroke, vol. 33, no. 7, pp. 1763–1771, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Barber, P. Langhorne, A. Rumley, G. D. O. Lowe, and D. J. Stott, “Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression,” Stroke, vol. 35, no. 6, pp. 1421–1425, 2004. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Cushman, A. R. Folsom, L. Wang et al., “Fibrin fragment D-dimer and the risk of future venous thrombosis,” Blood, vol. 101, no. 4, pp. 1243–1248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Cassar, P. Bachoo, I. Ford, M. Greaves, and J. Brittenden, “Markers of coagulation activation, endothelial stimulation and inflammation in patients with peripheral arterial disease,” European Journal of Vascular and Endovascular Surgery, vol. 29, no. 2, pp. 171–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. P. M. De Maat, E. M. Bladbjerg, T. Drivsholm, K Borch-Johnsen, L. Møller, and J. Jespersen, “Inflammation, thrombosis and atherosclerosis: results of the Glostrup study,” Journal of Thrombosis and Haemostasis, vol. 1, no. 5, pp. 950–957, 2003. View at Google Scholar
  15. H. J. Cohen, T. Harris, and C. F. Pieper, “Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly,” American Journal of Medicine, vol. 114, no. 3, pp. 180–187, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. G. D. O. Lowe, “Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease,” Journal of Thrombosis and Haemostasis, vol. 3, no. 8, pp. 1618–1627, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. Souto, L. Almasy, M. Borrell et al., “Genetic determinants of hemostasis phenotypes in Spanish families,” Circulation, vol. 101, no. 13, pp. 1546–1551, 2000. View at Google Scholar · View at Scopus
  18. R. A. S. Ariëns, M. de Lange, H. Snieder, M. Boothby, T. D. Spector, and P. J. Grant, “Activation markers of coagulation and fibrinolysis in twins: heritability of the prethrombotic state,” Lancet, vol. 359, no. 9307, pp. 667–671, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Peetz, A. Victor, P. Adams et al., “Genetic and environmental influences on the fibrinolytic system: a twin study,” Thrombosis and Haemostasis, vol. 92, no. 2, pp. 344–351, 2004. View at Google Scholar · View at Scopus
  20. C. Y. Vossen, S. J. Hasstedt, F. R. Rosendaal et al., “Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family,” Journal of Thrombosis and Haemostasis, vol. 2, no. 2, pp. 242–247, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. E. M. Bladbjerg, M. P. M. De Maat, K. Christensen, L. Bathum, J. Jespersen, and J. Hjelmborg, “Genetic influence on thrombotic risk markers in the elderly—a Danish twin study,” Journal of Thrombosis and Haemostasis, vol. 4, no. 3, pp. 599–607, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. F. M. K. Williams, A. M. Carter, B. Kato et al., “Identification of quantitative trait loci for fibrin clot phenotypes: the EuroCLOT study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 4, pp. 600–605, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. S. B. Harrap and J. L. Hopper, “Genetics of haemostasis,” Lancet, vol. 357, no. 9250, pp. 83–84, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Soria, L. Almasy, J. C. Souto et al., “A quantitative-trait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease,” American Journal of Human Genetics, vol. 70, no. 3, pp. 567–574, 2002. View at Publisher · View at Google Scholar · View at Scopus
  25. J. W. MacCluer, M. P. Stern, L. Almasy et al., “Genetics of atherosclerosis risk factors in Mexican Americans,” Nutrition Reviews, vol. 57, no. 5, pp. S59–S65, 1999. View at Google Scholar · View at Scopus
  26. P. J. Declerck, P. Mombaerts, P. Holvoet, M. De Mol, and D. Collen, “Fibrinolytic response and fibrin fragment D-dimer levels in patients with deep vein thrombosis,” Thrombosis and Haemostasis, vol. 58, no. 4, pp. 1024–1029, 1987. View at Google Scholar · View at Scopus
  27. P. A. Sakkinen, E. M. Macy, P. W. Callas et al., “Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology,” American Journal of Epidemiology, vol. 149, no. 3, pp. 261–267, 1999. View at Google Scholar · View at Scopus
  28. M. R. Lewis, P. W. Callas, N. S. Jenny, and R. P. Tracy, “Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples,” Thrombosis and Haemostasis, vol. 86, no. 6, pp. 1495–1500, 2001. View at Google Scholar · View at Scopus
  29. G. D. O. Lowe, “Venous and arterial thrombosis: epidemiology and risk factors at various ages,” Maturitas, vol. 47, no. 4, pp. 259–263, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. O. Wu, L. Robertson, P. Langhorne et al., “Oral contraceptives, hormone replacement therapy, thrombophilias and risk of venous thromboembolism: a systematic review. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) Study,” Thrombosis and Haemostasis, vol. 94, no. 1, pp. 17–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  31. E. Sobel, J. C. Papp, and K. Lange, “Detection and integration of genotyping errors in statistical genetics,” American Journal of Human Genetics, vol. 70, no. 2, pp. 496–508, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. L. Almasy and J. Blangero, “Multipoint quantitative-trait linkage analysis in general pedigrees,” American Journal of Human Genetics, vol. 62, no. 5, pp. 1198–1211, 1998. View at Publisher · View at Google Scholar · View at Scopus
  33. S. C. Heath, “Markov chain Monte Carlo segregation and linkage analysis for oligogenic models,” American Journal of Human Genetics, vol. 61, no. 3, pp. 748–760, 1997. View at Google Scholar · View at Scopus
  34. A. Kong, D. F. Gudbjartsson, J. Sainz et al., “A high-resolution recombination map of the human genome,” Nature Genetics, vol. 31, no. 3, pp. 241–247, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Sabater-Lleal, A. Buil, J. C. Souto et al., “A genome-wide exploration suggests an oligogenic model of inheritance for the TAFI activity and its antigen levels,” Human Genetics, vol. 124, no. 1, pp. 81–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. L. Almasy, J. M. Soria, J. C. Souto et al., “A locus on chromosome 2 influences levels of tissue factor pathway inhibitor: results from the GAIT study,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 7, pp. 1489–1492, 2005. View at Publisher · View at Google Scholar · View at Scopus